The fact, that most participants were recruited through the consultation for hereditary breast and ovarian cancer may lead also to a selection bias Additionally, TP53 PV carriers were able to select participating relatives among all their relatives, leading to an additional selection bias. This evidence concerns the gene TP53 and ovarian carcinoma.